首页|胎心监护仪持续监测在待产产妇中的应用价值分析

胎心监护仪持续监测在待产产妇中的应用价值分析

扫码查看
目的 探究胎心监护仪持续监测在待产产妇中的应用价值。方法 选择 120 例待产产妇作为研究对象,采用 1∶1 随机数字表法分为对照组和监测组,每组 60 例。两组均行正常的护理干预,在此基础上,对照组给予常规产前检查,自行开展胎动计数并按时产检;监测组给予电子胎心监护仪持续监测。对比两组监测结果、产程、分娩恐惧感、不良妊娠结局发生情况及新生儿Apgar评分。结果 监测组胎动异常、胎心异常、产前胎心监护无应激试验(NST)异常检出率分别为 33。33%、36。67%、33。33%,均明显高于对照组的 15。00%、16。67%、15。00%(P<0。05)。监测组第一产程、第二产程和第三产程分别为(5。11±0。59)、(0。95±0。05)、(0。33±0。03)h,均明显短于对照组的(7。23±0。77)、(1。92±0。22)、(0。71±0。19)h(P<0。05)。干预 4 周,两组分娩恐惧感评分均较本组干预前有所降低,且监测组分娩恐惧感评分(70。19±4。28)分显著低于对照组的(83。15±5。81)分(P<0。05);分娩前,两组分娩恐惧感评分均较干预 4 周有所升高,但监测组分娩恐惧感评分(80。22±4。16)分明显低于对照组的(87。88±4。61)分(P<0。05)。监测组不良妊娠结局发生率为 8。33%,明显低于对照组的 23。33%(P<0。05)。两组新生儿出生 5、10 min的Apgar评分均明显高于本组出生 1 min,出生 10 min的Apgar评分均明显高于本组出生 5 min,且监测组新生儿出生 1、5、10 min的Apgar评分分别为(7。31±0。26)、(8。57±0。33)、(9。58±0。35)分,均明显高于对照组的(6。47±0。29)、(7。63±0。37)、(8。79±0。26)分(P<0。05)。结论 对待产产妇应用胎心监护仪持续监测,可对其指标进行有效监测,降低其对分娩的恐惧感、不良妊娠结局发生率,提高新生儿Apgar评分,应用价值较高,值得在临床推广应用。
Analysis of the application value of continuous monitoring of fetal heart rate monitor in expectant mothers
Objective To explore the application value of continuous monitoring of fetal heart rate monitor in expectant mothers.Methods 120 cases of expectant mothers were selected as the study subjects,and were divided into the control group and the monitoring group by the 1∶1 randomized numerical table method,with 60 cases in each group.Both groups underwent normal nursing interventions,based on which the control group was given routine prenatal checkups,fetal movement counting at home and scheduled prenatal checkups;the monitoring group was given continuous monitoring by remote electronic fetal heart rate monitors.The monitoring results,duration of labor,fear of childbirth,occurrence of adverse pregnancy outcomes and neonatal Apgar score were compared between the two groups.Results The detection rates of abnormal fetal movement,abnormal fetal heartbeat,and abnormal prenatal non-stress test(NST)in the monitoring group were 33.33%,36.67%,and 33.33%,which were significantly higher than 15.00%,16.67%,and 15.00%in the control group(P<0.05).The duration of first,second and third stages of labor in the monitoring group were(5.11±0.59),(0.95±0.05)and(0.33±0.03)h,which were significantly shorter than(7.23±0.77),(1.92±0.22)and(0.71±0.19)h in the control group(P<0.05).After 4 weeks of intervention,the score of fear of childbirth in both groups was lower than that before intervention,and the score of fear of childbirth of(70.19±4.28)points in the monitoring group was significantly lower than(83.15±5.81)points in the control group(P<0.05).Before delivery,the score of fear of childbirth in both groups was higher than that after 4 weeks of intervention,but the score of fear of childbirth in the monitoring group[(80.22±4.16)points]was significantly lower than that in the control group[(87.88±4.61)points](P<0.05).The incidence of adverse pregnancy outcome in the monitoring group was 8.33%,which was significantly lower than 23.33%in the control group(P<0.05).The Apgar scores at 5 and 10 min after birth in both groups was significantly higher than those at 1 min after birth in this group,and the Apgar score at 10 min after birth was significantly higher than that at 5 min after birth in this group;the Apgar scores were(7.31±0.26),(8.57±0.33)and(9.58±0.35)points at 1,5 and 10 min after birth in the monitoring group,which were significantly higher than(6.47±0.29),(7.63±0.37)and(8.79±0.26)points in the control group(P<0.05).Conclusion The application of continuous monitoring of the fetal heart monitor for expectant women can effectively monitor their indicators,reduce their fear of childbirth,lower the incidence of adverse pregnancy outcomes,and improve the Apgar score of the newborn,which has high application value and is worth popularizing and applying in the clinic.

Fetal heart rate monitorExpectant mothersDelivery outcomeApplication value

黄仲梅

展开 >

354000 福建省邵武市立医院产科

胎心监护仪 待产产妇 分娩结局 应用价值

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(24)